Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.33 |
| ▸ | PGK1 | P00558 | 1/20 | 0.32 |
| ▸ | PGK2 | P07205 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18242513 | 0.95 | NFE2L2 (0.34) | NFE2L2PGK1PGK2 | |
| SCHEMBL18242756 | 0.87 | NFE2L2 (0.36) | NFE2L2PGK1PGK2 | |
| SCHEMBL18378492 | 0.83 | NFE2L2 (0.32) | NFE2L2PGK1PGK2 | |
| SCHEMBL18242217 | 0.81 | NFE2L2 (0.31) | NFE2L2 | |
| SCHEMBL18244036 | 0.80 | NFE2L2 (0.30) | NFE2L2 | |
| SCHEMBL18242450 | 0.79 | TSHR (0.42) | NFE2L2PGK1PGK2 | |
| SCHEMBL18242861 | 0.77 | NFE2L2 (0.33) | NFE2L2PGK1PGK2 | |
| SCHEMBL18242274 | 0.77 | — | — | |
| SCHEMBL18378489 | 0.76 | NFE2L2 (0.32) | NFE2L2PGK1PGK2 | |
| SCHEMBL18242909 | 0.75 | NFE2L2 (0.31) | NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2019-10-22 | — | — | US | disclosed |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) | 2016-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10451967-B2 | Acid- and radical-generating agent and method for generating acid and radical | CBR1, HAO2, CBR3 | NFE2L2 45/4885PGK1 2952/4885PGK2 2580/4885 |
| US-20160342084-A1 | ACID- AND RADICAL-GENERATING AGENT AND METHOD FOR GENERATING ACID AND RADICAL | CBR1, HAO2, CBR3 | NFE2L2 45/4885PGK1 2952/4885PGK2 2580/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.